SAN

76.29

-0.51%↓

ARGX

768

-2.19%↓

SHL.DE

35.08

+0.8%↑

PHIA

23.29

+2.42%↑

FRE

38.79

+3%↑

SAN

76.29

-0.51%↓

ARGX

768

-2.19%↓

SHL.DE

35.08

+0.8%↑

PHIA

23.29

+2.42%↑

FRE

38.79

+3%↑

SAN

76.29

-0.51%↓

ARGX

768

-2.19%↓

SHL.DE

35.08

+0.8%↑

PHIA

23.29

+2.42%↑

FRE

38.79

+3%↑

SAN

76.29

-0.51%↓

ARGX

768

-2.19%↓

SHL.DE

35.08

+0.8%↑

PHIA

23.29

+2.42%↑

FRE

38.79

+3%↑

SAN

76.29

-0.51%↓

ARGX

768

-2.19%↓

SHL.DE

35.08

+0.8%↑

PHIA

23.29

+2.42%↑

FRE

38.79

+3%↑

Fagron

Отворен

СекторЗдравеопазване

24.55 -0.81

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

24.4

Максимум

24.85

Ключови измерители

By Trading Economics

Приходи

-99K

45M

Продажби

-98K

476M

P/E

Средно за сектора

19.194

49.052

Дивидентна доходност

1.69

Марж на печалбата

9.55

Служители

4,193

EBITDA

11M

98M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+20.59% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

1.69%

2.36%

Следващи печалби

30.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

116M

1.7B

Предишно отваряне

25.36

Предишно затваряне

24.55

Настроения в новините

By Acuity

50%

50%

146 / 342 Класиране в Healthcare

Fagron Графика

Миналото представяне не гарантира бъдещи резултати.

Относно Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat